Harvard Apparatus Regenerative Technology, Inc. (NASDAQ: HART), a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, will hold a conference call to discuss recent events at 11:00 AM (Eastern Time) on December 23, 2014. On that call, management may take questions from the audience on any of a number of topics related to the business, including operations, plans and outlook.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
